Dermochinona en es it fr

Dermochinona Brand names, Dermochinona Analogs

Dermochinona Brand Names Mixture

  • No information avaliable

Dermochinona Chemical_Formula


Dermochinona RX_link

Dermochinona fda sheet

Dermochinona msds (material safety sheet)

Dermochinona MSDS

Dermochinona Synthesis Reference

No information avaliable

Dermochinona Molecular Weight

414.476 g/mol

Dermochinona Melting Point

No information avaliable

Dermochinona H2O Solubility


Dermochinona State


Dermochinona LogP


Dermochinona Dosage Forms

Powder for solution

Dermochinona Indication

For the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs.

Dermochinona Pharmacology

Nafcillin is a semisynthetic antibiotic substance derived from 6-amino-penicillanic acid. The drugs in this class are highly resistant to inactivation by staphylococcal penicillinase and are active against penicillinase-producing and non penicillinase-producing strains of Staphylococcus aureus. The penicillinase- resistant penicillins are active in vitro against a variety of other bacteria.

Dermochinona Absorption

No information avaliable

Dermochinona side effects and Toxicity

Serious toxicity is unlikely following large doses of nafcillin. Acute ingestion of large doses of nafcillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses.

Dermochinona Patient Information

Dermochinona Organisms Affected

Enteric bacteria and other eubacteria